Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026 Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4931394_CN31394_0